Only a few days into the job, new Gilead CEO Daniel O’Day has a key commercial position to fill. Late Tuesday, the big biotech said Alessandro Riva, M.D., its EVP of oncology, would leave the company. He’ll stay on through the end of the month, at which time he’ll take the helm of Glenmark Pharmaceuticals’… Read More: Gilead loses oncology leader Riva days into CEO O'Day's new… »
Mice with inflammatory bowel disease tried a vegan dietWestend61/Eva Gruendemann/Getty By Donna Lu A low-calorie diet may help alleviate the symptoms of inflammatory bowel disease (IBD). That’s according to experiments with mice with IBD who were fed a low-calorie, low-protein diet and had reduced intestinal inflammation and a regenerated gut as a result. In humans,… Read More: A temporary low-calorie diet may reduce inflammatory bowel disease »
Zoloft is a type of medication that doctors call a selective serotonin reuptake inhibitor, or SSRI. They may recommend it for mental health conditions, including certain types of bipolar disorder. There are some side effects to consider before using this drug, however, and some may be cause for concern. Anyone who is uncertain about their… Read More: Medical News Today: How does Zoloft affect bipolar disorder? »
FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the Treatment of ADHD Print this page STAMFORD, Conn.–(BUSINESS WIRE) March 01, 2019 –Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for… Read More: FDA Approves Adhansia XR (methylphenidate hydrochloride) Extended-Release Capsules for the… »